Figures & data
Figure 1 The clinical course and treatments.
Abbreviations: mPSL, methylprednisolone; PSL, prednisolone; CsA, cyclosporine-A; IVCY, intravenous cyclophosphamide; RTX, rituximab; MMF, mycophenolate mofetil; HLH, hemophagocytic lymphohistiocytosis; IL-6, interleukin-6; CSF, cerebrospinal fluid.
![Figure 1 The clinical course and treatments.](/cms/asset/338dc7ef-c075-40b7-a0eb-7ae5fb295daa/dtcr_a_167109_f0001_c.jpg)
Figure 2 Changes in brain magnetic resonance imaging (FLAIR images).
Notes: (A) At the time of the PML onset. (B) A month and half after PML onset before starting treatment by mefloquine and mirtazapine. (C) Two months after the start of treatment by mefloquine and mirtazapine. (D) Eight months after the onset of PML and 6 months after the start of treatment by mefloquine and mirtazapine.
Abbreviations: FLAIR, fluid-attenuated inversion recovery; PML, progressive multifocal leukoencephalopathy.
Abbreviations: FLAIR, fluid-attenuated inversion recovery; PML, progressive multifocal leukoencephalopathy.
![Figure 2 Changes in brain magnetic resonance imaging (FLAIR images).](/cms/asset/1f41d013-c1c1-40d9-a656-4c53c872fc3a/dtcr_a_167109_f0002_b.jpg)